CITADEL ADVISORS LLC 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 6:18 pm Sale | 2023-12-31 | 13G | Jasper Therapeutics, Inc. JSPR | CITADEL ADVISORS LLC | 230,620 0.200% | -142,287 (-38.16%) | Filing |
| 2023-02-14 08:26 am Purchase | 2022-12-31 | 13G | Jasper Therapeutics, Inc. JSPR | CITADEL ADVISORS LLC | 372,907 9.900% | 4,787 (+1.30%) | Filing |
| 2022-02-14 06:30 am Sale | 2021-12-31 | 13G | Jasper Therapeutics, Inc. JSPR | CITADEL ADVISORS LLC | 368,120 9.900% | -186 (-0.05%) | Filing |
| 2021-10-04 4:02 pm Purchase | 2021-09-24 | 13G | Jasper Therapeutics, Inc. JSPR | CITADEL ADVISORS LLC | 368,306 9.900% | 368,306 (New Position) | Filing |